Sentinel node biopsy in cutaneous melanoma patients: Technical and clinical aspects

D. Casara, D. Rubello, C. R. Rossi, B. Scagnet, S. Mocellin, P. Pilati, M. Foletto, M. C. Montesco, A. Tregnaghi, L. Rubaltelli, M. Lise

Research output: Contribution to journalArticlepeer-review


The role of the patent blue dye (PBD) technique and intraoperative probe-guided lymphoscintigraphy (LS) in detecting the sentinel node (SN) was investigated in a group of 130 consecutive stage I cutaneous melanoma patients. The preoperative workup included high-resolution US scanning and LS performed 15-18 hours before surgery. On the basis of preoperative LS, in the group of examined patients a total of 143 lymphatic drainage basins were identified and surgically explored: 41.6% in the axilla, 52.8% in the groin, and 5.6% in the head/neck. A total of 228 SNs were intraoperatively detected and removed; 110 lymphatic basins contained histologically negative SNs, while 33 basins had metastatic SNs. The sensitivity for SN detection using PBD alone was 93%, while it was 100% when PBD was combined with intraoperative LS. Preoperative and intraoperative LS appears to be a highly sensitive technique for SN detection in cutaneous melanoma patients. Furthermore, in view of the limited skin incision when radioguided surgery is performed, SN biopsy could be feasible under local anesthesia.

Original languageEnglish
Pages (from-to)339-340
Number of pages2
Issue number4
Publication statusPublished - 2000


  • Lymphoscintigraphy
  • Melanoma
  • Patent blue dye
  • Sentinel node

ASJC Scopus subject areas

  • Cancer Research


Dive into the research topics of 'Sentinel node biopsy in cutaneous melanoma patients: Technical and clinical aspects'. Together they form a unique fingerprint.

Cite this